Tatva Chintan Pharma Chem Limited (BOM:543321)
India flag India · Delayed Price · Currency is INR
1,197.15
+5.70 (0.48%)
At close: Jun 18, 2026

Tatva Chintan Pharma Chem Statistics

Total Valuation

BOM:543321 has a market cap or net worth of INR 27.93 billion. The enterprise value is 29.05 billion.

Market Cap27.93B
Enterprise Value 29.05B

Important Dates

The next estimated earnings date is Friday, July 24, 2026.

Earnings Date Jul 24, 2026
Ex-Dividend Date Sep 12, 2025

Share Statistics

Current Share Class 23.39M
Shares Outstanding n/a
Shares Change (YoY) -0.01%
Shares Change (QoQ) +0.16%
Owned by Insiders (%) 74.16%
Owned by Institutions (%) 6.62%
Float 6.04M

Valuation Ratios

The trailing PE ratio is 66.41 and the forward PE ratio is 38.58.

PE Ratio 66.41
Forward PE 38.58
PS Ratio 5.52
PB Ratio 3.57
P/TBV Ratio 3.60
P/FCF Ratio n/a
P/OCF Ratio 88.70
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 69.07
EV / Sales 5.74
EV / EBITDA 31.18
EV / EBIT 51.58
EV / FCF n/a

Financial Position

The company has a current ratio of 1.64, with a Debt / Equity ratio of 0.15.

Current Ratio 1.64
Quick Ratio 0.60
Debt / Equity 0.15
Debt / EBITDA 1.29
Debt / FCF -1.46
Interest Coverage 19.75

Financial Efficiency

Return on equity (ROE) is 5.53% and return on invested capital (ROIC) is 4.85%.

Return on Equity (ROE) 5.53%
Return on Assets (ROA) 3.83%
Return on Invested Capital (ROIC) 4.85%
Return on Capital Employed (ROCE) 7.12%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee 7.45M
Profits Per Employee 619,352
Employee Count679
Asset Turnover 0.55
Inventory Turnover 1.36

Taxes

In the past 12 months, BOM:543321 has paid 149.55 million in taxes.

Income Tax 149.55M
Effective Tax Rate 26.23%

Stock Price Statistics

The stock price has increased by +26.37% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change +26.37%
50-Day Moving Average 1,237.62
200-Day Moving Average 1,243.87
Relative Strength Index (RSI) 49.73
Average Volume (20 Days) 3,066

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, BOM:543321 had revenue of INR 5.06 billion and earned 420.54 million in profits. Earnings per share was 17.98.

Revenue5.06B
Gross Profit 2.81B
Operating Income 563.11M
Pretax Income 570.09M
Net Income 420.54M
EBITDA 931.58M
EBIT 563.11M
Earnings Per Share (EPS) 17.98
Full Income Statement

Balance Sheet

The company has 87.91 million in cash and 1.20 billion in debt, with a net cash position of -1.12 billion.

Cash & Cash Equivalents 87.91M
Total Debt 1.20B
Net Cash -1.12B
Net Cash Per Share n/a
Equity (Book Value) 7.82B
Book Value Per Share 334.03
Working Capital 1.36B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 314.89 million and capital expenditures -1.14 billion, giving a free cash flow of -822.85 million.

Operating Cash Flow 314.89M
Capital Expenditures -1.14B
Depreciation & Amortization 368.47M
Net Borrowing 839.86M
Free Cash Flow -822.85M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 55.61%, with operating and profit margins of 11.13% and 8.31%.

Gross Margin 55.61%
Operating Margin 11.13%
Pretax Margin 11.27%
Profit Margin 8.31%
EBITDA Margin 18.42%
EBIT Margin 11.13%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 0.08%.

Dividend Per Share 1.00
Dividend Yield 0.08%
Dividend Growth (YoY) -50.00%
Years of Dividend Growth n/a
Payout Ratio 5.56%
Buyback Yield 0.01%
Shareholder Yield 0.10%
Earnings Yield 1.51%
FCF Yield -2.95%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Analyst Forecast

The average price target for BOM:543321 is 1,390.00, which is 16.11% higher than the current price. The consensus rating is "Hold".

Price Target 1,390.00
Price Target Difference 16.11%
Analyst Consensus Hold
Analyst Count 3
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 5